NCT04907838 is a NA clinical trial of Insulin clamp in Type2 Diabetes, sponsored by University of Southern Denmark.

Who is sponsoring NCT04907838?

NCT04907838 is sponsored by University of Southern Denmark.

What drugs are being tested in NCT04907838?

Interventions in NCT04907838: Insulin clamp, BQ123, BQ123 + BQ788.

What condition does NCT04907838 study?

NCT04907838 studies Type2 Diabetes.

Is NCT04907838 still recruiting?

NCT04907838 is currently status unknown. Last updated 1 June 2021.

Last reviewed 2021-06-01 · How we verify

NCT04907838

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Insulin Stimulated Vasodilation in Patients With Type 2 Diabetes

Status unknown NA Last updated 1 June 2021

What this trial tests

NA trial testing Insulin clamp in Type2 Diabetes in 22 participants. Status unknown.

Timeline

1 May 2018

Primary endpoint
30 July 2021

30 July 2021

Quick facts

Lead sponsor	University of Southern Denmark
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	22
Start date	1 May 2018
Primary completion	30 July 2021
Estimated completion	30 July 2021
Sites	1 location across Denmark

Drugs / interventions tested

Insulin clamp — full drug profile →
BQ123 — full drug profile →
BQ123 + BQ788 — full drug profile →

Conditions studied

Type2 Diabetes — all drugs for Type2 Diabetes →

Sponsor

University of Southern Denmark

Who can join

Adults 40 to 65, any sex, with Type2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the role of endothelin in insulin stimulated vasodilation and glucose uptake. The subjects will complete an hyperinsulinemic euglycemic clamp with and without blockade of the endothelin receptors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Role of Endothelin-1 Receptors in Limiting Leg Blood Flow and Glucose Uptake During Hyperinsulinemia in Type 2 Diabetes.
Young BE, Padilla J, Finsen SH, Fadel PJ, et al · · 2022 · cited 7× · PMID 35084435 · DOI 10.1210/endocr/bqac008

Verify or expand the search:

Other recruiting trials for Type2 Diabetes

Currently open trials in the same condition.

NCT05277558 — Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) · recruiting
NCT05015283 — Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission · NA · recruiting
NCT05006508 — Prevention With the Health and Lifestyle Tool · NA · active not recruiting
NCT04717050 — Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity · NA · active not recruiting
NCT05220917 — Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study · active not recruiting

Other University of Southern Denmark trials

Trials by the same sponsor.

NCT07531290 — PeerScreen Trial - Reducing Screen Media Use in Peer-groups of Young People · NA · not yet recruiting
NCT07384273 — Evaluating the Effectiveness of an Internet-based Therapy (iCARE) to Treat Symptoms of Postpartum Depression · NA · recruiting
NCT07426679 — Should Anaesthesiologists Be Taught to Perform Ultrasound-- Assisted Neuraxial Access in Spinal Anaesthesia? · NA · recruiting
NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
NCT07194759 — Health Literacy Levels of Patients Living With Type 2 Diabetes and Multi-disease and Their Families Using HLQTM · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04907838 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Southern Denmark
Last refreshed: 1 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04907838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing